{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:56Z","timestamp":1786119716358,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/mjt.0b013e3181f65503","type":"journal-article","created":{"date-parts":[[2010,11,13]],"date-time":"2010-11-13T04:20:29Z","timestamp":1289622029000},"page":"14-22","source":"Crossref","is-referenced-by-count":30,"title":["A Randomized, Open-Label Pilot Study Comparing Desirudin and Argatroban in Patients With Suspected Heparin-Induced Thrombocytopenia With or Without Thrombosis: PREVENT-HIT Study"],"prefix":"10.1097","volume":"18","author":[{"given":"Steven W","family":"Boyce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis F","family":"Bandyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Bartholomew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N","family":"Frame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210202","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMra044440","article-title":"Direct thrombin inhibitors.","volume":"353","author":"Di Nisio","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-5-20210202","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1378\/chest.08-0689","article-title":"Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.).","volume":"133","author":"Hirsh","year":"2008","journal-title":"Chest"},{"key":"R3-5-20210202","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ahj.2009.01.005","article-title":"Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: the Complications After Thrombocytopenia Caused by Heparin (CATCH) registry.","volume":"157","author":"Crespo","year":"2009","journal-title":"Am Heart J"},{"key":"R4-5-20210202","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"R5-5-20210202","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/archinte.163.20.2518","article-title":"An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.","volume":"163","author":"Warkentin","year":"2003","journal-title":"Arch Intern Med"},{"key":"R6-5-20210202","doi-asserted-by":"crossref","first-page":"S340","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.).","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"key":"R7-5-20210202","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMcp052967","article-title":"Clinical practice. Heparin-induced thrombocytopenia.","volume":"355","author":"Arepally","year":"2006","journal-title":"N Engl J Med"},{"key":"R8-5-20210202","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.amjsurg.2009.01.029","article-title":"Heparin-induced thrombocytopenia in surgical patients.","volume":"199","author":"Battistelli","year":"2010","journal-title":"Am J Surg"},{"key":"R9-5-20210202","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1378\/chest.127.2_suppl.35S","article-title":"New approaches to the diagnosis of heparin-induced thrombocytopenia.","volume":"127","author":"Warkentin","year":"2005","journal-title":"Chest"},{"key":"R10-5-20210202","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archinte.164.4.361","article-title":"Treatment of heparin-induced thrombocytopenia: a critical review.","volume":"164","author":"Hirsh","year":"2004","journal-title":"Arch Intern Med"},{"key":"R11-5-20210202","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(02)07495-0","article-title":"Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients data.","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"R12-5-20210202","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-2001-17964","article-title":"Clinical monitoring of hirudin and direct thrombin inhibitors.","volume":"27","author":"Nowak","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"R14-5-20210202","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/01.CIR.103.14.1838","article-title":"Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.","volume":"103","author":"Lewis","year":"2001","journal-title":"Circulation"},{"key":"R15-5-20210202","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.163.15.1849","article-title":"Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.","volume":"163","author":"Lewis","year":"2003","journal-title":"Arch Intern Med"},{"key":"R17-5-20210202","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2106\/00004623-199703000-00002","article-title":"Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.","volume":"79","author":"Eriksson","year":"1997","journal-title":"J Bone Joint Surg Am"},{"key":"R18-5-20210202","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM199711063371901","article-title":"A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.","volume":"337","author":"Eriksson","year":"1997","journal-title":"N Engl J Med"},{"key":"R19-5-20210202","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199509213331203","article-title":"A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators.","volume":"333","author":"Serruys","year":"1995","journal-title":"N Engl J Med"},{"key":"R20-5-20210202","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.89.4.1557","article-title":"Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.","volume":"89","author":"Topol","year":"1994","journal-title":"Circulation"},{"key":"R21-5-20210202","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1161\/01.CIR.90.4.1631","article-title":"The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.","volume":"90","year":"1994","journal-title":"Circulation"},{"key":"R22-5-20210202","first-page":"775","article-title":"The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators.","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"R23-5-20210202","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.CIR.94.5.911","article-title":"Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.","volume":"94","author":"Antman","year":"1996","journal-title":"Circulation"},{"key":"R24-5-20210202","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/01.CIR.90.4.1624","article-title":"Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.","volume":"90","author":"Antman","year":"1994","journal-title":"Circulation"},{"key":"R25-5-20210202","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0735-1097(94)90581-9","article-title":"A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.","volume":"23","author":"Cannon","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"R26-5-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9149(99)80517-7","article-title":"Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial.","volume":"75","author":"Lee","year":"1995","journal-title":"Am J Cardiol"},{"key":"R27-5-20210202","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/01.CIR.88.5.2058","article-title":"Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.","volume":"88","author":"van den Bos","year":"1993","journal-title":"Circulation"},{"key":"R28-5-20210202","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.thromres.2005.02.010","article-title":"Direct thrombin inhibitors are not equally effective in vivo against arterial thrombosis: in vivo evaluation of DuP714 and argatroban in a porcine angioplasty model and comparison to r-hirudin.","volume":"116","author":"McBane","year":"2005","journal-title":"Thromb Res"},{"key":"R29-5-20210202","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.beha.2004.02.002","article-title":"Bivalent direct thrombin inhibitors: hirudin and bivalirudin.","volume":"17","author":"Warkentin","year":"2004","journal-title":"Best Pract Res Clin Haematol"},{"key":"R30-5-20210202","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0049-3848(90)90120-2","article-title":"Effect of a synthetic thrombin-inhibitor MD805 on the reaction between thrombin and plasma antithrombin-III.","volume":"59","author":"Hijikata-Okunomiya","year":"1990","journal-title":"Thromb Res"},{"key":"R31-5-20210202","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1021\/bi00417a048","article-title":"Use of site-directed mutagenesis to investigate the basis for the specificity of hirudin.","volume":"27","author":"Braun","year":"1988","journal-title":"Biochemistry (Mosc)"},{"key":"R32-5-20210202","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.clinthera.2010.04.012","article-title":"Rationale and design of the PREVENT-HIT Study: a randomized, open-label, pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.","volume":"32","author":"Frame","year":"2010","journal-title":"Clin Ther"},{"key":"R34-5-20210202","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1001\/archinte.164.18.1961","article-title":"Heparin-induced thrombocytopenia: myths and misconceptions (that will cause trouble for you and your patient).","volume":"164","author":"Rice","year":"2004","journal-title":"Arch Intern Med"},{"key":"R35-5-20210202","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1378\/chest.07-0425","article-title":"Who is (still) getting HIT?","volume":"131","author":"Warkentin","year":"2007","journal-title":"Chest"},{"key":"R36-5-20210202","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1378\/chest.127.5.1488","article-title":"Finding haystacks full of needles: from Opus to Osler.","volume":"127","author":"Levine","year":"2005","journal-title":"Chest"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00045391-201101000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:49:49Z","timestamp":1786042189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201101000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181f65503","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}